DRI Healthcare Trust (DRI Healthcare Trust) Change In Inventory : $0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is DRI Healthcare Trust Change In Inventory?

DRI Healthcare Trust's change in inventory for the quarter that ended in Mar. 2024 was $0.0 Mil. It means DRI Healthcare Trust's inventory stayed the same from Dec. 2023 to Mar. 2024 .

DRI Healthcare Trust's change in inventory for the fiscal year that ended in Dec. 2023 was $0.0 Mil. It means DRI Healthcare Trust's inventory stayed the same from Dec. 2022 to Dec. 2023 .

DRI Healthcare Trust's Total Inventories for the quarter that ended in Mar. 2024 was $0.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. DRI Healthcare Trust's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.00.

DRI Healthcare Trust Change In Inventory Historical Data

The historical data trend for DRI Healthcare Trust's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust Change In Inventory Chart

DRI Healthcare Trust Annual Data

Trend

Dec21

Dec22

Dec23

Change In Inventory

DRI Healthcare Trust Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial								-	-	-	-	-

DRI Healthcare Trust Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

DRI Healthcare Trust (OTCPK:DHTRF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

DRI Healthcare Trust's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

DRI Healthcare Trust's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

DRI Healthcare Trust's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	25.054
	=	0.00

DRI Healthcare Trust Change In Inventory Related Terms

Thank you for viewing the detailed overview of DRI Healthcare Trust's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

DRI Healthcare Trust (DRI Healthcare Trust) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (OTCPK:DHTRF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

DHT.UN:Canada DHT.U:Canada

Address

100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1

Website

https://www.dricapital.com

DRI Healthcare Trust is a pioneer in global pharmaceutical royalty monetization with a more than 30-year history of accelerating innovation by providing capital to inventors, academic institutions, and biopharma companies. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world.